Alpha Ketoglutarate Enhances Geroprotection In Surgery (AEGIS)
NCT07031128 · Status: RECRUITING · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 250
Last updated 2025-06-22
Summary
One of the most common major surgeries that older patients undergo is coronary artery bypass grafting surgery (CABG), which is performed in approximately 400,000 patients in the United States each year. CABG invokes a massive surgical stress response, with systemic epinephrine increasing 33-fold and norepinephrine increasing 3-fold. Initially, local tissue injury results in a sterile inflammation, releasing damage-associated molecular patterns (DAMPS). DAMPS activate neutrophils, bringing a cascade of cytokines, complement, and coagulation changes. Activation of nociceptors results in a neurometabolic response involving the sympathetic nervous system and hypothalamus-pituitary axis. This brings about systemic effects including changes in basal metabolic rate, hyperglycemia, lipolysis, negative nitrogen balance, and release of cytokines and complement. Although the surgical stress response is essential for wound healing and is usually self-limiting, an exaggerated response may occur resulting in multiple organ dysfunction.
The acute phase of the surgical stress response is often followed by secondary insults that may be either sterile or pathogen-induced (such as postoperative infection).In the "two-hit" model of surgical stress response, there is an exaggerated response even to minor insults in vulnerable individuals who were primed by the initial stress response. Changes in the microbiome may also occur, developing a "pathobiome" that may enter the systemic circulation. If left unchecked, this second hit may result in the development of systemic inflammatory response syndrome (SIRS) and multi-organ failure.
Chronological ageing changes the innate and adaptive immunity of patients. Biological hallmarks of aging such as genomic instability, mitochondrial damage, glycation of proteins, and cellular senescence all result in increased oxidative stress and systemic inflammation. Aging brings about a pro-inflammatory innate immune responsiveness that often occurs even in the absence of an inflammatory threat. This is termed inflammaging. Paradoxically, inflammaging is associated with an increased risk of infection and poor response to stressful events. At the same time, there is an age-associated loss of T-cell function, particularly in naïve CD8 T-cells. This deficit is termed immunosenescence and is characterised by reduced pathogen recognition, chemotaxis, and phagocytosis.
Conditions
- CABG
Interventions
- DIETARY_SUPPLEMENT
-
Alpha-ketoglutarate
Alpha-ketoglutarate supplements
- DIETARY_SUPPLEMENT
-
Placebo
Placebo tablets
Sponsors & Collaborators
-
Wellcome Leap Inc.
collaborator INDUSTRY -
National University Hospital, Singapore
lead OTHER
Principal Investigators
-
Lian Kah Ti · National University Hospital, Singapore
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 50 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-06-11
- Primary Completion
- 2026-12-31
- Completion
- 2026-12-31
Countries
- Singapore
Study Locations
More Related Trials
-
Preparation of Patients for Cardiac Surgery
NCT00906646 ·Status: COMPLETED ·Phase: PHASE3
-
Dietary Supplements in Patients With Coronary Artery Bypass Grafting for Improving the Quality of Healthcare Delivery.
NCT06995586 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Myocardial Protection With Multiport Antegrade Cold Blood Cardioplegia
NCT02303704 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Preoperative Stellate Ganglion Block on Postoperative Atrial Fibrillation After Coronary Artery Bypass Grafting
NCT07271615 ·Status: RECRUITING ·Phase: NA
-
Effects of Microplegia on Transfusion Rates After Cardiac Surgery
NCT05076604 ·Status: COMPLETED ·Phase: PHASE4
-
Association Between GalectiN-3 and POSt-operative AtrIal Fibrillation After Coronary Artery BypaSs Graft
NCT06768528 ·Status: RECRUITING
-
Histidine-Tryptophan-Ketoglutarate Solution Versus Blood Cardioplegia in CABG
NCT04203680 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Investigation of Myocardial Protection Level With Specific Cardioplegia Methods in Cardiac Surgery
NCT05603429 ·Status: COMPLETED
-
Multidisciplinary CAE and CABG Surgery to Optimize the Management of High-risk Patients During the Perioperative Period
NCT04960488 ·Status: COMPLETED ·Phase: NA
-
Electroacupuncture for Heart Protection: Clinical Application in Patients Undergoing Cardiac Bypass Surgery
NCT05514067 ·Status: COMPLETED ·Phase: NA
-
Etomidate Versus Propofol in CABG Surgery
NCT06068764 ·Status: RECRUITING ·Phase: PHASE4
-
Prevention of Autogenous Vein Graft Failure in Coronary Artery Bypass Procedures
NCT00042081 ·Status: COMPLETED ·Phase: PHASE3
-
The Effect Of Acadesine On Reducing Cardiovascular and Cerebrovascular Adverse Events In Coronary Artery Bypass Graft (CABG) Surgery (Study P05633 AM1)(TERMINATED)
NCT00872001 ·Status: TERMINATED ·Phase: PHASE3
-
Innovative Strategies For Risk Reduction Following CABG
NCT00462436 ·Status: COMPLETED ·Phase: PHASE2
-
Antegrade and Retrograde Versurs Antegrade Cardioplegia in Complex Coronary Artery Bypass Surgeries
NCT04439162 ·Status: UNKNOWN ·Phase: NA
-
Role of Calcium Chloride Injection in Alleviating Atrial Fibrillation Post CABG
NCT06378021 ·Status: RECRUITING ·Phase: PHASE3
-
Effect of Remote Ischemic Preconditioning on the Incidence of Acute Kidney Injury in Patients Undergoing Coronary Artery Bypass Graft Surgery
NCT02981680 ·Status: COMPLETED ·Phase: NA
-
Vitamin C in Cardiac Surgery Patients
NCT03123107 ·Status: COMPLETED ·Phase: PHASE1
-
Mini Versus Conventional Cardiopulmonary Bypass In CABG in Asian Patients
NCT03657225 ·Status: COMPLETED ·Phase: NA
-
Prolonged Cardiopulmonary Bypass Time as a Predictive Factor for AGI After Heart Valve Replacement
NCT05498935 ·Status: COMPLETED
-
The Effect of 6% Hydroxyethyl Starch 130/0.4 on Blood Loss and Coagulation in Patients Medicated With Antiplatelet Agents Prior to Off-Pump Coronary Bypass Graft Surgery
NCT01051206 ·Status: COMPLETED ·Phase: PHASE4
-
Clinical Study to Evaluate Nesiritide in Patients Undergoing Coronary Artery Bypass Graft (CABG) Surgery A014 / NAPA
NCT00653042 ·Status: COMPLETED ·Phase: PHASE2
-
The Perioperative Risks of Adverse Events After Cardiac Surgery: a Retrospective Study
NCT04476134 ·Status: UNKNOWN
-
SGC Stimulation, Perioperative Vascular Reactivity, and Organ Injury in Cardiac Surgery
NCT05812755 ·Status: RECRUITING ·Phase: PHASE4
-
Single Dose Administration of Alpha-1 Anti-Trypsin for the Amelioration of Organ Injury in Patients Undergoing Cardiac Surgery
NCT02191839 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2